Rejected at 4:41 p.m. Dec, 20, 2024 ] by IantheBFG
Author: ishwarm
Related Note: 1461806938449 1
Rationale for change

This card previously said "contraindicated in women of childbearing potential" which while partially correct, does not fully represent the information on AMBOSS on misoprostol contraindications.

AMBOSS directly states that it is contraindicated in:

"Pregnant women (when used to reduce the risk of NSAIA-induced gastric ulcers)."

As well as those with a known hypersensitivity to prostaglandins. Stating that misoprostol should be contraindicated in all patients with childbearing potential is too broad of a statement and may result in medical students (or even residents) not considering it when treating patients that have child-bearing capacity resulting in reduced patient outcomes and quality of care.

Furthermore, it is important for students to fully understand why or why not to use misoprostol with pregnant patients for the purposes of the USMLE Step 1 as well as to create a more well-rounded medical knowledge overall.
Source: AMBOSS - https://next.amboss.com/us/pharma/1391?ahfs_section=cauts%2Ccontra&q=misoprostol+contraindication#contra

Rejection reason

Thank you very much for your contribution! The wording is directly from First Aid on this medication and we believe this change is not needed at this time.

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step2_v12::#AMBOSS::86aO5l #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::16_Phosphodiesterase_inhibitors::*PGE1_Agonist::Misoprostol #AK_Step1_v12::^Systems::GI::pharm #AK_Step1_v12::#OME::04_Organ_Systems::03_Gastrointestinal::01_Digestion_&_Absorption::05_Physiology_and_Pharmacology_of_the_Stomach #AK_Step1_v12::#Bootcamp::Gastroenterology::04_Stomach::23_Additional_Gastric_Pharmacology #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::03_Gastrointestinal::01_Digestion_&_Absorption::05_Physiology_and_Pharmacology_of_the_Stomach #PANCE::GI::gastric_disorders #AK_Step1_v12::#Physeo::09_Pharm::11_Gastrointestinal::05_Misoprostol #AK_Step1_v12::#B&B::09_Endocrinology::04_Repro::04_Contraceptives #AK_Step1_v12::#SketchyPharm::04_Smooth_Muscle::01_Vasoactive::03_Prostaglandins,_Prostacyclin,_Bosentan,_PDE5_Inhibitors #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#AMBOSS::86aO5l #AK_Step2_v12::#SketchyOBGYN::01_Prenatal_Care_&_Early_Pregnancy::03_Early_Pregnancy_Complications::03_Early_Pregnancy_Loss #AK_Step1_v12::#FirstAid::09_Gastrointestinal::05_Pharm::06_Misoprostol